Bone marrow, adipose, and lung tissue-derived murine mesenchymal stromal cells release different mediators and differentially affect airway and lung parenchyma in experimental asthma

Stem Cells Translational Medicine

Volumn 6, Issue 6, 2017, Pages 1557-1567

  Abreu, Soraia C ^a   Antunes, Mariana A ^a   Xisto, Debora G ^a   Cruz, Fernanda F ^a   Branco, Vivian C ^a   Bandeira, Elga ^a,b   Kitoko, Jamil Zola ^a,c   De Araú Jo, Almair F ^c   Dellatorre Texeira, Ludmilla ^c   Olsen, Priscilla C ^c   Weiss, Daniel J ^d   Diaz, Bruno L ^c   Morales, Marcelo M ^b   Rocco, Patricia R M ^a  

^a Laboratory of Pulmonary Investigation   (Brazil)

^b Laboratory of Cellular and Molecular Physiology   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

Asthma; Fibrosis; Inflammation; Macrophage; Mesenchymal stromal cells

Indexed keywords

EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN RECEPTOR; AUTACOID;

ADIPOSE TISSUE CELL; AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW STROMA CELL; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; CELL COUNT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL ASTHMA; FEMALE; FLOW CYTOMETRY; LEUKOCYTE COUNT; LUNG PARENCHYMA; MALE; MESENCHYMAL STROMA CELL; MORPHOMETRY; MOUSE; MRNA EXPRESSION ASSAY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TIDAL VOLUME; ADIPOSE TISSUE; ANIMAL; ASTHMA; BONE MARROW CELL; C57BL MOUSE; CLASSIFICATION; CYTOLOGY; LUNG; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PROCEDURES; TRACHEA;

ADIPOSE TISSUE; ANIMALS; ASTHMA; BONE MARROW CELLS; FEMALE; INFLAMMATION MEDIATORS; LUNG; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; TRACHEA;

EID: 85020128867     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.1002/sctm.16-0398     Document Type: Article

References (38)

1. Al-Muhsen S, Johnson JR, Hamid Q. Remodeling in asthma. J Allergy Clin Immunol 2011;128:451–462; quiz 463–454.
2. Cruz FF, Borg ZD, Goodwin M et al. Systemic administration of human bone marrowderived mesenchymal stromal cell extracellular vesicles ameliorates aspergillus hyphal extract-induced allergic airway inflammation in immunocompetent mice. STEM CELL TRANSL MED 2015;4:1302–1316.
3. Fu QL, Chow YY, Sun SJ et al. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy 2012;67:1215–1222.
4. Lathrop MJ, Brooks EM, Bonenfant NR et al. Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the th17 signaling pathway. STEM CELLS TRANSL MED 2014;3:194–205.
5. Jang HJ, Cho KS, Park HY et al. Adipose tissue-derived stem cells for cell therapy of airway allergic diseases in mouse. Acta Histochem 2011;113:501–507.
6. Cho KS, Roh HJ. Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases. Curr Stem Cell Res Ther 2010;5:111–115.
7. Bentley JK, Popova AP, Bozyk PD et al. Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype. Respir Res 2010;11:127.
8. Jarvinen L, Badri L, Wettlaufer S et al. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol 2008;181:4389–4396.
9. Chiu CJ, Ling TY, Chiang BL. Lung-derived SSEA-1(1) stem/progenitor cells inhibit allergic airway inflammation in mice. Allergy 2015; 70:374–383.
10. Ostanin AA, Petrovskii YL, Shevela EY et al. Multiplex analysis of cytokines, chemokines, growth factors, MMP-9 and TIMP-1 produced by human bone marrow, adipose tissue, and placental mesenchymal stromal cells. Bull Exp Biol Med 2011;151:133–141.
11. Ricciardi M, Malpeli G, Bifari F et al. Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. PLoS One 2012;7:e35639.
12. Xisto DG, Farias LL, Ferreira HC et al. Lung parenchyma remodeling in a murine model of chronic allergic inflammation. Am J Respir Crit Care Med 2005;171:829–837.
13. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119(Pt 11):2204–2213.
14. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–317.
15. Rocco PR, Negri EM, Kurtz PM et al. Lung tissue mechanics and extracellular matrix remodeling in acute lung injury. Am J Respir Crit Care Med 2001;164:1067–1071.
16. Burburan SM, Xisto DG, Ferreira HC et al. Lung mechanics and histology during sevoflurane anesthesia in a model of chronic allergic asthma. Anesth Analg 2007;104:631–637.
17. Bates JH, Ludwig MS, Sly PD et al. Interrupter resistance elucidated by alveolar pressure measurement in open-chest normal dogs. J Appl Physiol (1985) 1988;65:408–414.
18. ER W. Morphometry: Stereological theory and practical methods. In: Gil J, ed. Models of Lung Disease-Microscopy and Structural Methods. New York: Marcel Dekker, 1990:199–247.
19. Hsia CC, Hyde DM, Ochs M et al. An official research policy statement of the American Thoracic Society/European Respiratory Society: Standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 2010;181:394–418.
20. Antunes MA, Abreu SC, Damaceno-Rodrigues NR et al. Different strains of mice present distinct lung tissue mechanics and extracellular matrix composition in a model of chronic allergic asthma. Respir Physiol Neurobiol 2009;165:202–207.
21. da Silva AL, Martini SV, Abreu SC et al. DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma. J Control Release 2014;180:125–133.
22. Antunes MA, Abreu SC, Silva AL et al. Sex-specific lung remodeling and inflammation changes in experimental allergic asthma. J Appl Physiol (1985) 2010;109:855–863.
23. Abreu SC, Antunes MA, Mendonca L et al. Effects of bone marrow mononuclear cells from healthy or ovalbumin-induced lung inflammation donors on recipient allergic asthma mice. Stem Cell Res Ther 2014;5:108.
24. Bustos ML, Huleihel L, Kapetanaki MG et al. Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response. Am J Respir Crit Care Med 2014;189:787–798.
25. Nemeth K, Keane-Myers A, Brown JM et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 2010;107:5652–5657.
26. Elahi KC, Klein G, Avci-Adali M et al. Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns. Stem Cells Int 2016;2016: 5646384.
27. Braza F, Dirou S, Forest V et al. Mesenchymal stem cells induce suppressive macrophages through phagocytosis in a mouse model of asthma. STEM CELLS 2016;34:1836–1845.
28. Bagheri M, Dong Y, Ono M. Molecular diversity of macrophages in allergic reaction: Comparison between the allergenic modes; Th1- and -Th2-derived immune conditions. Iran J Allergy Asthma Immunol 2015;14:261–272.
29. Foronjy RF, Majka SM. The potential for resident lung mesenchymal stem cells to promote functional tissue regeneration: Understanding microenvironmental cues. Cells 2012; 1:874.
30. Firinci F, Karaman M, Baran Y et al. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011; 11:1120–1126.
31. Goodwin M, Sueblinvong V, Eisenhauer P et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. STEM CELLS 2011; 29:1137–1148.
32. Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE et al. Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects. Cryobiology 2015;71:181–197.
33. Hoffman AM, Paxson JA, Mazan MR et al. Lung-derived mesenchymal stromal cell posttransplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Stem Cells Dev 2011;20:1779–1792.
34. Marinas-Pardo L, Mirones I, Amor-Carro O et al. Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma. Allergy 2014;69: 730–740.
35. Martinez-Gonzalez I, Cruz MJ, Moreno R et al. Human mesenchymal stem cells resolve airway inflammation, hyperreactivity, and histopathology in a mouse model of occupational asthma. Stem Cells Dev 2014;23: 2352–2363.
36. Urbanek K, De Angelis A, Spaziano G et al. Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model. PLoS One 2016;11:e0158746.
37. Brown JM, Nemeth K, Kushnir-Sukhov NM et al. Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin Exp Allergy 2011;41:526–534.
38. Bonfield TL, Koloze M, Lennon DP et al. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010;299:L760–770.